Literature DB >> 3102560

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

F B Taylor, A Chang, C T Esmon, A D'Angelo, S Vigano-D'Angelo, K E Blick.   

Abstract

Gram-negative septicemia elicits multiple abnormalities of the coagulation system. Although products of coagulation can lead to clot formation, thereby potentiating organ damage, recent work has shown that low concentrations of thrombin can protect animals from the shock state. Because these amounts of thrombin also lead to formation in vivo of the anticoagulant enzyme, activated protein C, we examined the role of protein C in modulation of Escherichia coli shock in baboons. First, we infused activated protein C and lethal concentrations of E. coli organisms, which prevented the coagulopathic, hepatotoxic, and lethal effects of E. coli. Second, using an antibody to protein C we blocked protein C activation in vivo to determine if this influenced the response to lethal and sublethal concentrations of E. coli organisms. Under these conditions the response to lethal concentrations of E. coli organisms was made more severe and the response to sublethal concentrations of E. coli was made lethal. The coagulopathic, hepatotoxic, and lethal responses in this latter case were prevented by infusion of exogenous protein C.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102560      PMCID: PMC424237          DOI: 10.1172/JCI112902

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  A pathologic study of Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment.

Authors:  J J Coalson; B A Benjamin; L T Archer; B K Beller; R H Spaet; L B Hinshaw
Journal:  Surg Gynecol Obstet       Date:  1978-11

2.  Serum glutamic pyruvic transaminase in cardiac with hepatic disease.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Proc Soc Exp Biol Med       Date:  1956-04

3.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

4.  The role of fibrin monomer and an in vivo thrombin-induced-anticoagulant in experimental venous thrombosis.

Authors:  R Wetmore; V Gurewich
Journal:  Scand J Haematol       Date:  1974

5.  Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.

Authors:  R A Marlar; A J Kleiss; J H Griffin
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

6.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

8.  Preparation and properties of bovine factor VIII (antihemophilic factor).

Authors:  G A Vehar; E W Davie
Journal:  Biochemistry       Date:  1980-02-05       Impact factor: 3.162

9.  Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

Authors:  M E Nesheim; W M Canfield; W Kisiel; K G Mann
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

10.  Generation of fibrinolytic activity by infusion of activated protein C into dogs.

Authors:  P C Comp; C T Esmon
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  155 in total

1.  Treatment of sepsis with activated protein C.

Authors:  C J Hinds
Journal:  BMJ       Date:  2001-10-20

Review 2.  Emerging therapies in severe sepsis.

Authors:  S J Finney; T W Evans
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  Levels of plasma des-gamma-carboxy protein C and prothrombin in patients with liver diseases.

Authors:  Xiao-Fan He; Zhi-Bin Wen; Min-Juan Liu; Hui Zhang; Qun Li; Shi-Lin He
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 4.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

Review 5.  [Microcirculation and hemostasis in inflammatory processes. Modulation by administration of physiologic protease inhibitors as a therapeutic approach].

Authors:  B Leithäuser; F R Matthias
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 6.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

7.  Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis.

Authors:  Ravi Shankar Keshari; Robert Silasi; Narcis Ioan Popescu; Maulin Mukeshchandra Patel; Hala Chaaban; Cristina Lupu; K Mark Coggeshall; Tom Eirik Mollnes; Steven J DeMarco; Florea Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

8.  Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin.

Authors:  W A Dittman; T Kumada; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Antibody SPC-54 provides acute in vivo blockage of the murine protein C system.

Authors:  Laurent Burnier; José A Fernández; John H Griffin
Journal:  Blood Cells Mol Dis       Date:  2013-02-04       Impact factor: 3.039

Review 10.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.